User Profiles Site map description
M
- Martin Bousa
Marketing Executive at SAFINA, a.s. from Czech Republic · Prague
I am MSc graduated in Chemical engineering at University in Prague. Fields: inorganic and organic chemistry. More than 20 years in innovations of products, technologies, innovative market business development. Author of several patents in hydromet. Recent successfull solver of challenge for IdeaConnection (non sticky chewing gum). Operate my own lab. - Martin Jack
Unlock Your Potential with Customized Assessment Help from United Kingdom · Manchester
Hi there, I'm Martin Jack and I'm an assessment helper focused on education. With years of experience in the field, I have helped countless students and professionals alike to unlock their full potential and achieve their goals. So if you're looking for an assessment help service provider who is dedicated to your success, look no further than Martin Jack. Let's work together to unlock your full potential and achieve your goals. - Martin Machin
Co-Founder at Quantum-South from Uruguay
Martin is a mentor, investor and advisor to companies in information and emerging technologies, and previously was managing partner in Pyxis, the fastest growing IT company in Uruguay in the last decade, expanding to Latin America and North America. Before that, Martin led the Global Delivery Center of Tata Consultancy Services in Montevideo and was Head of the Banking, Financial Services and Insurance Area of the operation. He also worked at IBM, Conaprole, and Banco Comercial which was later acquired by Scotiabank, and was Artificial Intelligence professor in the Universidad Católica del Uruguay. - Martin Perez-Santos
Licensing Manager at Benemérita Universidad Autónoma de Puebla from Mexico
In addition to my research interest, I am the head of the innovation and business area of the Benemerita Universidad Autonoma de Puebla. This area is responsible for the registration and licensing of patents at the university, as well as the creation of technology companies. My research interest is in the area of immunotherapy, particularly in agonist or antagonist antibodies directed against checkpoint molecules in cancer, such as PD-1, PD-L1, CTLA-4, LAG3 and OX40.